39
https://pubmed.ncbi.nlm.nih.gov/38093371
Metabolic dysfunction-associated fatty liver disease (MAFLD) and its subtypes are associated with increased systemic atherosclerosis, suggesting that addressing fatty liver disease may help reduce its deleterious effects on the cardiovascular system.
